Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Catapano

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|April 1, 1991
Nuclear matrix targets for anticancer agentsD J Fernandes, C V Catapano
Nucleic Acids Research|June 13, 2002
Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc geneE M McGuffie, C V Catapano
International Review of Cytology|January 1, 1995
The nuclear matrix as a site of anticancer drug actionD J Fernandes, C V Catapano
Biochemistry|December 17, 1996
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicityJ Qiu, C V Catapano, D J Fernandes
Advances in Enzyme Regulation|January 1, 1995
DNA topoisomerase II isozymes involved in anticancer drug action and resistanceD J Fernandes, J Qiu, C V Catapano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
The nuclear matrix as a target for cancer therapyC V Catapano, G M Carbone, D J Fernandes
Biochemical Pharmacology|May 30, 2001
Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cellsG M Carbone, C V Catapano, D J Fernandes
Cancer Chemotherapy and Pharmacology|October 11, 2001
Synergistic interaction between topotecan and microtubule-interfering agentsH R Bahadori, M R Green, C V Catapano
Cancer Research|April 1, 1991
Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphateC V Catapano, K B Chandler, D J Fernandes
Cancer Treatment Reviews|December 1, 1988
Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyM D'Incalci, L Citti, P Taverna, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|April 1, 1991
Nuclear matrix targets for anticancer agentsD J Fernandes, C V Catapano
Nucleic Acids Research|June 13, 2002
Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc geneE M McGuffie, C V Catapano
International Review of Cytology|January 1, 1995
The nuclear matrix as a site of anticancer drug actionD J Fernandes, C V Catapano
Biochemistry|December 17, 1996
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicityJ Qiu, C V Catapano, D J Fernandes
Advances in Enzyme Regulation|January 1, 1995
DNA topoisomerase II isozymes involved in anticancer drug action and resistanceD J Fernandes, J Qiu, C V Catapano
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
The nuclear matrix as a target for cancer therapyC V Catapano, G M Carbone, D J Fernandes
Biochemical Pharmacology|May 30, 2001
Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cellsG M Carbone, C V Catapano, D J Fernandes
Cancer Chemotherapy and Pharmacology|October 11, 2001
Synergistic interaction between topotecan and microtubule-interfering agentsH R Bahadori, M R Green, C V Catapano
Cancer Research|April 1, 1991
Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphateC V Catapano, K B Chandler, D J Fernandes
Cancer Treatment Reviews|December 1, 1988
Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyM D'Incalci, L Citti, P Taverna, et al.
Pageof 4